Pharmaceutical Pipeline

Multipotent pharmacological activity, together with an excellent safety profile, makes Botamedi's marine phytochemicals extraordinary.
Based on unprecedented medicinal characteristics not found elsewhere, a spectrum of drug candidates that could overcome the current therapeutic limits in major incurable diseases are under development in collaboration with worldwide expert groups.

PH100 Tablet for Diabetic Complications (Phase II)
75%
PH733 for Neurodegeneration (Preclinical)
40%
PH300 Injectable for Systemic Inflammations (Preclinical)
30%
Conjugates for Oncology (Preclinical)
25%

We provide marine phytochemical-based therapeutics that are safe, effective, and beneficial for human, animal and ecological well-being.

We pursue the triple happiness - for ourselves, our partners, and our customers.

We aim to establish a new-paradigm therapeutic approach based on both safe and effective marine phytochemicals, in order to prevent and manage the currently-incurable chronic degenerative diseases that have prevailed in the 21st century.

LEARN MORE ABOUT SEANOL®

  

Seanol Science Center